“…Since then, there have been a number of reports detailing the prevalence, antimicrobial susceptibility patterns, and genetic diversity among serotype 6C isolates collected from both invasive disease and nasopharyngeal colonization studies (Campos et al, 2009;Carvalho et al, 2009;du Plessis et al, 2008;Green et al, 2011;Hermans et al, 2008;Jacobs et al, 2008Jacobs et al, , 2009Nahm et al, 2009;Nunes et al, 2009;Rolo et al, 2011a;Tocheva et al, 2010). In studies that looked at the prevalence of serotype 6C among invasive and carriage isolates, it was found that anywhere between 5% and 100% of isolates that originally typed as 6A were subsequently identified as serotype 6C (Campos et al, 2009;Carvalho et al, 2009;du Plessis et al, 2008;Hermans et al, 2008;Jacobs et al, 2009;Millar et al, 2010;Rolo et al, 2011a).…”